Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
Infection and viral entry of SARS-CoV-2 crucially depends on the binding of its Spike protein to angiotensin converting enzyme 2 (ACE2) presented on host cells. Glycosylation of both proteins is critical for this interaction. Recombinant soluble human ACE2 can neutralize SARS-CoV-2 and is currently...
Váldodahkkit: | , , , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
eLife Sciences Publications Ltd
2021-12-01
|
Ráidu: | eLife |
Fáttát: | |
Liŋkkat: | https://elifesciences.org/articles/73641 |